Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2023 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease.
Curr Hypertens Rep. 2023 Aug;25(8):151-162. doi: 10.1007/s11906-023-01242-8. Epub 2023 May 16.
Curr Hypertens Rep. 2023.
PMID: 37191842
Free PMC article.
Review.
Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content.
Kipp ZA, Martinez GJ, Bates EA, Maharramov AB, Flight RM, Moseley HNB, Morris AJ, Stec DE, Hinds TD Jr.
Kipp ZA, et al.
Metabolites. 2023 Feb 1;13(2):215. doi: 10.3390/metabo13020215.
Metabolites. 2023.
PMID: 36837834
Free PMC article.
Item in Clipboard
Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease.
Bates EA, Kipp ZA, Martinez GJ, Badmus OO, Soundarapandian MM, Foster D, Xu M, Creeden JF, Greer JR, Morris AJ, Stec DE, Hinds TD Jr.
Bates EA, et al.
Biomolecules. 2023 Jan 29;13(2):252. doi: 10.3390/biom13020252.
Biomolecules. 2023.
PMID: 36830621
Free PMC article.
Item in Clipboard
Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1.
Hinds TD Jr, Creeden JF, Gordon DM, Spegele AC, Britton SL, Koch LG, Stec DE.
Hinds TD Jr, et al.
Antioxidants (Basel). 2020 Sep 19;9(9):889. doi: 10.3390/antiox9090889.
Antioxidants (Basel). 2020.
PMID: 32961782
Free PMC article.
Item in Clipboard
Cite
Cite